Temozolomide-Associated Organizing Pneumonitis
Temozolomide-Associated Organizing Pneumonitis
About this item
Full title
Temozolomide-Associated Organizing Pneumonitis
Author / Creator
Publisher
Elsevier Inc
Journal title
Mayo Clinic proceedings, 2007, Vol.82 (6), p.771-773
Language
English
Formats
Publication information
Publisher
Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Temozolomide is an oral alkylating agent recently approved for the treatment of glioblastoma multiforme. It has a favorable side effect profile and is generally well tolerated. Although mild respiratory symptoms have been described, pulmonary toxicity that requires discontinuation of therapy is rare. To our knowledge, this is the first case of temo...
Alternative Titles
Full title
Temozolomide-Associated Organizing Pneumonitis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_citationtrail_10_4065_82_6_771
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_citationtrail_10_4065_82_6_771
Other Identifiers
ISSN
0025-6196
E-ISSN
1942-5546
DOI
10.4065/82.6.771
How to access this item
Log in as a Library member
